This bill reauthorizes the National Dam Safety Program through 2028, extending funding and updating requirements for dam safety. It defines "small disadvantaged community" (under 50,000 population with income below 80% of state median) and ensures these communities receive priority for dam rehabilitation grants. Key provisions require dam owners to commit to long-term maintenance plans and mandate floodplain management plans - either already in place or developed within two years - to reduce flood risks and protect communities. The bill also establishes a risk-based priority system for states to allocate grants for high-hazard dams.
The HOUSES Act of 2023 allows states and local governments to purchase federal public lands for housing development, requiring at least 85% of the land to be used for residential housing, open space, green space, or community amenities like schools or health clinics. It sets specific rules, including a minimum density of 4 homes per acre, limits on commercial use (capping it at 15% of land), and requirements for infrastructure like transit hubs and utilities. The bill establishes a review process where the Secretary of the Interior must prioritize housing needs, complete decisions within one year, and sell land at a price calculated using a formula based on fair market value and prior tax revenue. This applies to tracts not designated as federally protected land, with non-compliance risking loss of federal community development funds for 15 years.
This bill blocks the EPA from implementing new vehicle emissions rules for model years 2027 and later, specifically targeting the "Multi-Pollutant Emissions Standards" rule. It amends the Clean Air Act to prevent future regulations from mandating specific technology (like electric components) or limiting the availability of new vehicles based on engine type (e.g., gasoline vs. electric). The bill directly affects the EPA’s authority to set emissions standards and the auto industry’s ability to sell certain vehicle types. It ensures emissions rules cannot restrict consumer choices among new vehicle models.
The PACE Act creates a federal grant program to prevent adverse childhood experiences (ACEs) - such as abuse, neglect, or household instability - and promote positive childhood experiences (PCEs), like supportive relationships and safe environments, for children under 18. It requires states, tribes, and local governments receiving grants to use data to target high-burden communities and implement evidence-based strategies through multi-sector partnerships, while funding research on ACEs and PCEs, including historical trauma’s impact. The bill authorizes funding for fiscal years 2024-2028 and mandates annual reports to Congress on program effectiveness.
S 3091, the Rural Inclusion Act, expands eligibility for Medicare rural emergency hospital designation to include specific rural clinics. It allows Federally Qualified Health Centers (FQHCs) that previously participated in a 2003 frontier clinic demonstration program to qualify as Medicare rural emergency hospitals. This change directly affects qualifying rural clinics and the Medicare beneficiaries they serve in remote areas. The bill amends the Social Security Act to update the definition of eligible facilities, ensuring these clinics can access Medicare reimbursement under the rural emergency hospital program.
The Breast Cancer Patient Equity Act would require Medicare to cover custom breast prostheses for women who have undergone mastectomies (surgical breast removal), an option currently excluded from Medicare coverage despite having a billing code. This change would directly affect women who choose non-surgical alternatives to reconstruction, including those denied coverage by Medicare and private insurers who follow Medicare's lead. The bill amends the Social Security Act to explicitly add "custom fabricated breast prostheses" to Medicare's covered services, including replacements, while maintaining existing coverage for surgical reconstruction. By closing this coverage gap, the bill aims to provide equitable access to a treatment option disproportionately unavailable to older and minority women.
This bill reinstates U.S. sanctions on Iran that were previously waived under an agreement between the U.S. and Iran, including a specific waiver related to funds from South Korea to Qatar (documented in a September 11, 2023, congressional transmission). It blocks any U.S. government action to release funds or assets to Iran under that agreement and prohibits future waivers, suspensions, or relief for these sanctions. The bill directly affects Iran's access to certain financial assets tied to the agreement. It targets concrete policy changes by reversing prior relief without altering broader sanctions frameworks.
S 3040, the True Reciprocity Act of 2023, directs the U.S. State Department to create a report assessing imbalances in how the U.S. and China treat each other’s diplomats, journalists, businesses, and nongovernmental organizations. The bill requires a 180-day report comparing restrictions on U.S. entities in China (like travel bans for citizens or limited access for journalists) against fewer restrictions on Chinese entities in the U.S. (such as unimpeded travel for Chinese diplomats). The report must include specific evaluations, like whether China complies with consular agreements and how internet restrictions affect business reciprocity. The bill itself does not change laws but sets a policy goal to pursue mutual treatment in future negotiations and strategy.
This bill permanently exempts foreign workers employed as fish roe processors, fish roe technicians, supervisors of fish roe processing, or general fish processors from the H-2B visa numerical cap. It defines "fish" broadly to include finfish, shellfish, roe, and all seafood processing activities (like handling, freezing, and packaging), but excludes marine mammals and birds. The bill replaces a temporary 2005 exemption with a permanent policy, directly affecting seafood processing employers and workers in these specific roles. It makes no changes to other H-2B visa categories or immigration pathways.
S.3028, the PUNISH Act of 2023, extends existing U.S. sanctions against Iran by preventing their modification or removal until a specified termination date. It requires the Secretary of State to submit annual reports to Congress assessing whether Iran's government or affiliated entities (like the Islamic Revolutionary Guard Corps) have engaged in activities such as assassinations, violence against U.S. citizens, or politically motivated detention of Iranian nationals in the U.S. The bill maintains current sanctions tied to Executive Orders 13871, 13876, 13902, and 13949, as well as sanctions on Iran's Central Bank and National Development Fund. These measures remain in effect until the President certifies compliance with specific conditions under the Comprehensive Iran Sanctions Act.
The Nutrition CARE Act of 2023 amends Medicare Part B to cover medical nutrition therapy services for beneficiaries with eating disorders, which were previously excluded from coverage. It directly affects Medicare beneficiaries diagnosed with eating disorders, including those from underrepresented racial and ethnic groups disproportionately impacted by these conditions. The bill requires coverage for services provided by registered dietitians or nutrition professionals following referrals from physicians or psychologists, mandating a minimum of 13 hours of care in the first year (including an initial assessment) and 4 hours annually thereafter. Coverage begins January 1, 2024, and applies specifically to eating disorders as defined by the Secretary using the DSM-5 criteria.
S 1624, the Gabriella Miller Kids First Research Act 2.0, redirects civil monetary penalties from securities violations to fund pediatric research. It transfers fines collected from companies violating food, drug, supplement, and cosmetic regulations (under the Securities Exchange Act) into a dedicated NIH pediatric research fund. The bill amends the Public Health Service Act to require the NIH Director to coordinate pediatric research using these funds and avoid duplication of existing efforts. It also mandates a 4-year report to Congress detailing funded projects and advancements in pediatric research. This policy change directly affects the NIH, pediatric research initiatives, and companies subject to the securities penalties.
